Vaxart
VXRT
#9401
Rank
ยฃ64.59 M
Marketcap
ยฃ0.27
Share price
-2.70%
Change (1 day)
-45.42%
Change (1 year)

Revenue for Vaxart (VXRT)

Revenue in 2025 (TTM): ยฃ60.88 Million

According to Vaxart's latest financial reports the company's current revenue (TTM ) is ยฃ60.33 Million. In 2024 the company made a revenue of ยฃ22.87 Million an increase over the revenue in the year 2023 that were of ยฃ5.79 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vaxart from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ60.88 M166.2%
2024 ยฃ22.87 M294.86%
2023 ยฃ5.79 M6448.74%
2022 ยฃ0.08 M-86.62%
2021 ยฃ0.66 M-77.74%
2020 ยฃ2.96 M-60.53%
2019 ยฃ7.52 M129.54%
2018 ยฃ3.27 M-43.23%
2017 ยฃ5.77 M-26.58%
2016 ยฃ7.86 M-13.06%
2015 ยฃ9.04 M-73.18%
2014 ยฃ33.72 M5.85%
2013 ยฃ31.85 M319.28%
2012 ยฃ7.59 M-20.41%
2011 ยฃ9.54 M-57.9%
2010 ยฃ22.67 M249.83%
2009 ยฃ6.48 M
2006 ยฃ45.88 M-20.61%
2005 ยฃ57.79 M-38.28%
2004 ยฃ93.63 M-5.14%
2003 ยฃ98.7 M-19.24%
2002 ยฃ0.12 B-24.54%
2001 ยฃ0.16 B5.66%
2000 ยฃ0.15 B6.02%
1999 ยฃ0.14 B-1.1%
1998 ยฃ0.14 B5.01%
1997 ยฃ0.13 B-0.59%
1996 ยฃ0.14 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
ยฃ0.10 B 72.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas